Retinal Imaging in CNTF -Releasing Encapsulated Cell Implant Treated Patients for Early-stage Retinitis Pigmentosa

Clinical trial NCT01530659 · COMPLETED

Trial details

NCT number: NCT01530659
Sponsor: Neurotech Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Retinitis Pigmentosa Usher Syndrome Type 2 Usher Syndrome Type 3

Start date: 2012-01-01
Primary completion: 2019-07-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.